Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 614 entries
Sorted by: Best Match Show Resources per page
Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.

Advances in therapy

Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C.
PMID: 28452039
Adv Ther. 2017 Jun;34(6):1498-1499. doi: 10.1007/s12325-017-0537-4.

No abstract available.

Cite
Omboni S, Malacco E, Napoli C, et al. Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies. Adv Ther. 2017;34(6):1498-1499doi: 10.1007/s12325-017-0537-4.
Omboni, S., Malacco, E., Napoli, C., Modesti, P. A., Manolis, A., Parati, G., Agabiti-Rosei, E., & Borghi, C. (2017). Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies. Advances in therapy, 34(6), 1498-1499. https://doi.org/10.1007/s12325-017-0537-4
Omboni, Stefano, et al. "Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies." Advances in therapy vol. 34,6 (2017): 1498-1499. doi: https://doi.org/10.1007/s12325-017-0537-4
Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C. Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies. Adv Ther. 2017 Jun;34(6):1498-1499. doi: 10.1007/s12325-017-0537-4. PMID: 28452039; PMCID: PMC5487858.
Copy Download .nbib Format: NLM
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage.

Auto- immunity highlights

Sangineto M, Luglio CV, Suppressa P, Sabbà C, Napoli N.
PMID: 28455816
Auto Immun Highlights. 2017 Dec;8(1):6. doi: 10.1007/s13317-017-0094-5. Epub 2017 Apr 28.

Sarcoidosis is a systemic disease characterized by an immune-mediated disorder, which leads to the development of non-caseating granulomas in the involved organs. More than 90% of patients with sarcoidosis present lungs and lymphatic system involvement at onset, while less...

Cite
Sangineto M, Luglio CV, Suppressa P, et al. A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage. Auto Immun Highlights. 2017;8(1):6doi: 10.1007/s13317-017-0094-5.
Sangineto, M., Luglio, C. V., Suppressa, P., Sabbà, C., & Napoli, N. (2017). A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage. Auto- immunity highlights, 8(1), 6. https://doi.org/10.1007/s13317-017-0094-5
Sangineto, Moris, et al. "A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage." Auto- immunity highlights vol. 8,1 (2017): 6. doi: https://doi.org/10.1007/s13317-017-0094-5
Sangineto M, Luglio CV, Suppressa P, Sabbà C, Napoli N. A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage. Auto Immun Highlights. 2017 Dec;8(1):6. doi: 10.1007/s13317-017-0094-5. Epub 2017 Apr 28. PMID: 28455816; PMCID: PMC5408327.
Copy Download .nbib Format: NLM
Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control.

International journal of stem cells

De Pascale MR, Bruzzese G, Crimi E, Grimaldi V, Liguori A, Brongo S, Barbieri M, Picascia A, Schiano C, Sommese L, Ferrara N, Paolisso G, Napoli C.
PMID: 27426095
Int J Stem Cells. 2016 May 30;9(1):137-44. doi: 10.15283/ijsc.2016.9.1.137.

BACKGROUND: Circulating endothelial progenitors cells (EPCs) play a critical role in neovascularization and endothelial repair. There is a growing evidence that hyperglycemia related to Diabetes Mellitus (DM) decreases EPC number and function so promoting vascular complications.AIM OF THE STUDY:...

Cite
De Pascale MR, Bruzzese G, Crimi E, et al. Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control. Int J Stem Cells. 2016;9(1):137-44doi: 10.15283/ijsc.2016.9.1.137.
De Pascale, M. R., Bruzzese, G., Crimi, E., Grimaldi, V., Liguori, A., Brongo, S., Barbieri, M., Picascia, A., Schiano, C., Sommese, L., Ferrara, N., Paolisso, G., & Napoli, C. (2016). Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control. International journal of stem cells, 9(1), 137-44. https://doi.org/10.15283/ijsc.2016.9.1.137
De Pascale, Maria Rosaria, et al. "Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control." International journal of stem cells vol. 9,1 (2016): 137-44. doi: https://doi.org/10.15283/ijsc.2016.9.1.137
De Pascale MR, Bruzzese G, Crimi E, Grimaldi V, Liguori A, Brongo S, Barbieri M, Picascia A, Schiano C, Sommese L, Ferrara N, Paolisso G, Napoli C. Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control. Int J Stem Cells. 2016 May 30;9(1):137-44. doi: 10.15283/ijsc.2016.9.1.137. PMID: 27426095; PMCID: PMC4961113.
Copy Download .nbib Format: NLM
Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts.

OncoTargets and therapy

De Tursi M, Zilli M, Carella C, Auriemma M, Lisco MN, Di Nicola M, Di Martino G, Natoli C, Amerio P.
PMID: 28670133
Onco Targets Ther. 2017 Jun 16;10:3007-3015. doi: 10.2147/OTT.S127795. eCollection 2017.

OBJECTIVES: The effectiveness of evaluation of the severity of epidermal growth-factor receptor inhibitor (EGFRI)-associated dermatological toxicities remains a topic of debate. This study was designed to assess the correlation between quality of life (QoL) and severity of dermatological toxicity,...

Cite
De Tursi M, Zilli M, Carella C, et al. Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts. Onco Targets Ther. 2017;10:3007-3015doi: 10.2147/OTT.S127795.
De Tursi, M., Zilli, M., Carella, C., Auriemma, M., Lisco, M. N., Di Nicola, M., Di Martino, G., Natoli, C., & Amerio, P. (2017). Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts. OncoTargets and therapy, 103007-3015. https://doi.org/10.2147/OTT.S127795
De Tursi, Michele, et al. "Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts." OncoTargets and therapy vol. 10 (2017): 3007-3015. doi: https://doi.org/10.2147/OTT.S127795
De Tursi M, Zilli M, Carella C, Auriemma M, Lisco MN, Di Nicola M, Di Martino G, Natoli C, Amerio P. Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts. Onco Targets Ther. 2017 Jun 16;10:3007-3015. doi: 10.2147/OTT.S127795. eCollection 2017. PMID: 28670133; PMCID: PMC5481280.
Copy Download .nbib Format: NLM
The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults.

Pharmacogenetics and genomics

Armamento-Villareal R, Wingkun N, Aguirre LE, Kulkarny V, Napoli N, Colleluori G, Qualls C, Villareal DT.
PMID: 26709911
Pharmacogenet Genomics. 2016 Apr;26(4):154-160. doi: 10.1097/FPC.0000000000000201.

OBJECTIVE: Fat mass and obesity-associated (FTO) gene polymorphisms have been reported to be associated with differences in BMI, obesity, and type 2 diabetes. However, previous studies have been predominantly conducted in younger individuals across a spectrum of body weights,...

Cite
Armamento-Villareal R, Wingkun N, Aguirre LE, et al. The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults. Pharmacogenet Genomics. 2016;26(4):154-160doi: 10.1097/FPC.0000000000000201.
Armamento-Villareal, R., Wingkun, N., Aguirre, L. E., Kulkarny, V., Napoli, N., Colleluori, G., Qualls, C., & Villareal, D. T. (2016). The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults. Pharmacogenetics and genomics, 26(4), 154-160. https://doi.org/10.1097/FPC.0000000000000201
Armamento-Villareal, Reina, et al. "The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults." Pharmacogenetics and genomics vol. 26,4 (2016): 154-160. doi: https://doi.org/10.1097/FPC.0000000000000201
Armamento-Villareal R, Wingkun N, Aguirre LE, Kulkarny V, Napoli N, Colleluori G, Qualls C, Villareal DT. The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults. Pharmacogenet Genomics. 2016 Apr;26(4):154-160. doi: 10.1097/FPC.0000000000000201. PMID: 26709911; PMCID: PMC4919233.
Copy Download .nbib Format: NLM
Leaching of Glyphosate and Aminomethylphosphonic Acid through Silty Clay Soil Columns under Outdoor Conditions.

Journal of environmental quality

Napoli M, Cecchi S, Zanchi CA, Orlandini S.
PMID: 26436283
J Environ Qual. 2015 Sep;44(5):1667-73. doi: 10.2134/jeq2015.02.0104.

Glyphosate [-(phosphono-methyl)-glycine] is the main herbicide used in the Chianti vineyards. Considering the pollution risk of the water table and that the vineyard tile drain may deliver this pollutant into nearby streams, the objective of the present study was...

Cite
Napoli M, Cecchi S, Zanchi CA, et al. Leaching of Glyphosate and Aminomethylphosphonic Acid through Silty Clay Soil Columns under Outdoor Conditions. J Environ Qual. 2015;44(5):1667-73doi: 10.2134/jeq2015.02.0104.
Napoli, M., Cecchi, S., Zanchi, C. A., & Orlandini, S. (2015). Leaching of Glyphosate and Aminomethylphosphonic Acid through Silty Clay Soil Columns under Outdoor Conditions. Journal of environmental quality, 44(5), 1667-73. https://doi.org/10.2134/jeq2015.02.0104
Napoli, Marco, et al. "Leaching of Glyphosate and Aminomethylphosphonic Acid through Silty Clay Soil Columns under Outdoor Conditions." Journal of environmental quality vol. 44,5 (2015): 1667-73. doi: https://doi.org/10.2134/jeq2015.02.0104
Napoli M, Cecchi S, Zanchi CA, Orlandini S. Leaching of Glyphosate and Aminomethylphosphonic Acid through Silty Clay Soil Columns under Outdoor Conditions. J Environ Qual. 2015 Sep;44(5):1667-73. doi: 10.2134/jeq2015.02.0104. PMID: 26436283.
Copy Download .nbib Format: NLM
Incidental Finding of an Isolated Double-orifice Mitral Valve in an Asymptomatic Man.

Journal of cardiovascular echography

Laccetta G, Napoli AM.
PMID: 28465972
J Cardiovasc Echogr. 2016 Jul-Sep;26(3):100-103. doi: 10.4103/2211-4122.187963.

Double-orifice mitral valve (DOMV) is a very rare congenital anomaly that usually presents as mitral regurgitation. We present the case of a 39-year-old asymptomatic, healthy man with no previous medical history who was affected by isolated complete bridge type...

Cite
Laccetta G, Napoli AM. Incidental Finding of an Isolated Double-orifice Mitral Valve in an Asymptomatic Man. J Cardiovasc Echogr. 2016;26(3):100-103doi: 10.4103/2211-4122.187963.
Laccetta, G., & Napoli, A. M. (2016). Incidental Finding of an Isolated Double-orifice Mitral Valve in an Asymptomatic Man. Journal of cardiovascular echography, 26(3), 100-103. https://doi.org/10.4103/2211-4122.187963
Laccetta, Gianluigi, and Napoli, Anna Maria. "Incidental Finding of an Isolated Double-orifice Mitral Valve in an Asymptomatic Man." Journal of cardiovascular echography vol. 26,3 (2016): 100-103. doi: https://doi.org/10.4103/2211-4122.187963
Laccetta G, Napoli AM. Incidental Finding of an Isolated Double-orifice Mitral Valve in an Asymptomatic Man. J Cardiovasc Echogr. 2016 Jul-Sep;26(3):100-103. doi: 10.4103/2211-4122.187963. PMID: 28465972; PMCID: PMC5224670.
Copy Download .nbib Format: NLM
Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data.

Frontiers in molecular biosciences

Grissa D, Pétéra M, Brandolini M, Napoli A, Comte B, Pujos-Guillot E.
PMID: 27458587
Front Mol Biosci. 2016 Jul 08;3:30. doi: 10.3389/fmolb.2016.00030. eCollection 2016.

Untargeted metabolomics is a powerful phenotyping tool for better understanding biological mechanisms involved in human pathology development and identifying early predictive biomarkers. This approach, based on multiple analytical platforms, such as mass spectrometry (MS), chemometrics and bioinformatics, generates massive...

Cite
Grissa D, Pétéra M, Brandolini M, et al. Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data. Front Mol Biosci. 2016;3:30doi: 10.3389/fmolb.2016.00030.
Grissa, D., Pétéra, M., Brandolini, M., Napoli, A., Comte, B., & Pujos-Guillot, E. (2016). Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data. Frontiers in molecular biosciences, 330. https://doi.org/10.3389/fmolb.2016.00030
Grissa, Dhouha, et al. "Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data." Frontiers in molecular biosciences vol. 3 (2016): 30. doi: https://doi.org/10.3389/fmolb.2016.00030
Grissa D, Pétéra M, Brandolini M, Napoli A, Comte B, Pujos-Guillot E. Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data. Front Mol Biosci. 2016 Jul 08;3:30. doi: 10.3389/fmolb.2016.00030. eCollection 2016. PMID: 27458587; PMCID: PMC4937038.
Copy Download .nbib Format: NLM
First Measurement of Several β-Delayed Neutron Emitting Isotopes Beyond N=126.

Physical review letters

Caballero-Folch R, Domingo-Pardo C, Agramunt J, Algora A, Ameil F, Arcones A, Ayyad Y, Benlliure J, Borzov IN, Bowry M, Calviño F, Cano-Ott D, Cortés G, Davinson T, Dillmann I, Estrade A, Evdokimov A, Faestermann T, Farinon F, Galaviz D, García AR, Geissel H, Gelletly W, Gernhäuser R, Gómez-Hornillos MB, Guerrero C, Heil M, Hinke C, Knöbel R, Kojouharov I, Kurcewicz J, Kurz N, Litvinov YA, Maier L, Marganiec J, Marketin T, Marta M, Martínez T, Martínez-Pinedo G, Montes F, Mukha I, Napoli DR, Nociforo C, Paradela C, Pietri S, Podolyák Z, Prochazka A, Rice S, Riego A, Rubio B, Schaffner H, Scheidenberger Ch, Smith K, Sokol E, Steiger K, Sun B, Taín JL, Takechi M, Testov D, Weick H, Wilson E, Winfield JS, Wood R, Woods P, Yeremin A.
PMID: 27419564
Phys Rev Lett. 2016 Jul 01;117(1):012501. doi: 10.1103/PhysRevLett.117.012501. Epub 2016 Jun 29.

The β-delayed neutron emission probabilities of neutron rich Hg and Tl nuclei have been measured together with β-decay half-lives for 20 isotopes of Au, Hg, Tl, Pb, and Bi in the mass region N≳126. These are the heaviest species...

Cite
Caballero-Folch R, Domingo-Pardo C, Agramunt J, et al. First Measurement of Several β-Delayed Neutron Emitting Isotopes Beyond N=126. Phys Rev Lett. 2016;117(1):012501doi: 10.1103/PhysRevLett.117.012501.
Caballero-Folch, R., Domingo-Pardo, C., Agramunt, J., Algora, A., Ameil, F., Arcones, A., Ayyad, Y., Benlliure, J., Borzov, I. N., Bowry, M., Calviño, F., Cano-Ott, D., Cortés, G., Davinson, T., Dillmann, I., Estrade, A., Evdokimov, A., Faestermann, T., Farinon, F., Galaviz, D., García, A. R., Geissel, H., Gelletly, W., Gernhäuser, R., Gómez-Hornillos, M. B., Guerrero, C., Heil, M., Hinke, C., Knöbel, R., Kojouharov, I., Kurcewicz, J., Kurz, N., Litvinov, Y. A., Maier, L., Marganiec, J., Marketin, T., Marta, M., Martínez, T., Martínez-Pinedo, G., Montes, F., Mukha, I., Napoli, D. R., Nociforo, C., Paradela, C., Pietri, S., Podolyák, Z., Prochazka, A., Rice, S., Riego, A., Rubio, B., Schaffner, H., Scheidenberger, C. h., Smith, K., Sokol, E., Steiger, K., Sun, B., Taín, J. L., Takechi, M., Testov, D., Weick, H., Wilson, E., Winfield, J. S., Wood, R., Woods, P., & Yeremin, A. (2016). First Measurement of Several β-Delayed Neutron Emitting Isotopes Beyond N=126. Physical review letters, 117(1), 012501. https://doi.org/10.1103/PhysRevLett.117.012501
Caballero-Folch, R, et al. "First Measurement of Several β-Delayed Neutron Emitting Isotopes Beyond N=126." Physical review letters vol. 117,1 (2016): 012501. doi: https://doi.org/10.1103/PhysRevLett.117.012501
Caballero-Folch R, Domingo-Pardo C, Agramunt J, Algora A, Ameil F, Arcones A, Ayyad Y, Benlliure J, Borzov IN, Bowry M, Calviño F, Cano-Ott D, Cortés G, Davinson T, Dillmann I, Estrade A, Evdokimov A, Faestermann T, Farinon F, Galaviz D, García AR, Geissel H, Gelletly W, Gernhäuser R, Gómez-Hornillos MB, Guerrero C, Heil M, Hinke C, Knöbel R, Kojouharov I, Kurcewicz J, Kurz N, Litvinov YA, Maier L, Marganiec J, Marketin T, Marta M, Martínez T, Martínez-Pinedo G, Montes F, Mukha I, Napoli DR, Nociforo C, Paradela C, Pietri S, Podolyák Z, Prochazka A, Rice S, Riego A, Rubio B, Schaffner H, Scheidenberger Ch, Smith K, Sokol E, Steiger K, Sun B, Taín JL, Takechi M, Testov D, Weick H, Wilson E, Winfield JS, Wood R, Woods P, Yeremin A. First Measurement of Several β-Delayed Neutron Emitting Isotopes Beyond N=126. Phys Rev Lett. 2016 Jul 01;117(1):012501. doi: 10.1103/PhysRevLett.117.012501. Epub 2016 Jun 29. PMID: 27419564.
Copy Download .nbib Format: NLM
Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases.

Journal of bone oncology

Quattrocchi CC, Dell'Aia P, Errante Y, Occhicone F, Longo D, Virzì V, Tonini G, Napoli N, Santini D, Beomonte Zobel B.
PMID: 26909251
J Bone Oncol. 2012 Mar 23;1(1):24-9. doi: 10.1016/j.jbo.2012.02.001. eCollection 2012 Jun.

PURPOSE: To evaluate bone density changes at the level of normal bone and bone metastases after zoledronic acid (ZA) treatment in oncologic patients.MATERIALS AND METHODS: We retrospectively evaluated 72 consecutive adult patients with histologically confirmed solid tumors with at...

Cite
Quattrocchi CC, Dell'Aia P, Errante Y, et al. Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases. J Bone Oncol. 2012;1(1):24-9doi: 10.1016/j.jbo.2012.02.001.
Quattrocchi, C. C., Dell'Aia, P., Errante, Y., Occhicone, F., Longo, D., Virzì, V., Tonini, G., Napoli, N., Santini, D., & Beomonte Zobel, B. (2012). Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases. Journal of bone oncology, 1(1), 24-9. https://doi.org/10.1016/j.jbo.2012.02.001
Quattrocchi, Carlo C, et al. "Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases." Journal of bone oncology vol. 1,1 (2012): 24-9. doi: https://doi.org/10.1016/j.jbo.2012.02.001
Quattrocchi CC, Dell'Aia P, Errante Y, Occhicone F, Longo D, Virzì V, Tonini G, Napoli N, Santini D, Beomonte Zobel B. Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases. J Bone Oncol. 2012 Mar 23;1(1):24-9. doi: 10.1016/j.jbo.2012.02.001. eCollection 2012 Jun. PMID: 26909251; PMCID: PMC4723329.
Copy Download .nbib Format: NLM
Imaging techniques for assessment of tubal status.

Journal of human reproductive sciences

Panchal S, Nagori C.
PMID: 24829524
J Hum Reprod Sci. 2014 Jan;7(1):2-12. doi: 10.4103/0974-1208.130797.

Fallopian tubes make a vital portal for transfer of gametes and embryo. Tubal factor is responsible for infertility in 25-35% of cases. Hysterosalpingography (HSG) has been used to evaluate the uterine cavity and the tubal status since decades. It...

Cite
Panchal S, Nagori C. Imaging techniques for assessment of tubal status. J Hum Reprod Sci. 2014;7(1):2-12doi: 10.4103/0974-1208.130797.
Panchal, S., & Nagori, C. (2014). Imaging techniques for assessment of tubal status. Journal of human reproductive sciences, 7(1), 2-12. https://doi.org/10.4103/0974-1208.130797
Panchal, Sonal, and Nagori, Chaitanya. "Imaging techniques for assessment of tubal status." Journal of human reproductive sciences vol. 7,1 (2014): 2-12. doi: https://doi.org/10.4103/0974-1208.130797
Panchal S, Nagori C. Imaging techniques for assessment of tubal status. J Hum Reprod Sci. 2014 Jan;7(1):2-12. doi: 10.4103/0974-1208.130797. PMID: 24829524; PMCID: PMC4018793.
Copy Download .nbib Format: NLM
Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding.

Frontiers in neuroscience

Napoli E, Ross-Inta C, Song G, Wong S, Hagerman R, Gane LW, Smilowitz JT, Tassone F, Giulivi C.
PMID: 27147951
Front Neurosci. 2016 Apr 19;10:159. doi: 10.3389/fnins.2016.00159. eCollection 2016.

Fragile X premutation alleles have 55-200 CGG repeats in the 5' UTR of the FMR1 gene. Altered zinc (Zn) homeostasis has been reported in fibroblasts from >60 years old premutation carriers, in which Zn supplementation significantly restored Zn-dependent mitochondrial...

Cite
Napoli E, Ross-Inta C, Song G, et al. Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding. Front Neurosci. 2016;10:159doi: 10.3389/fnins.2016.00159.
Napoli, E., Ross-Inta, C., Song, G., Wong, S., Hagerman, R., Gane, L. W., Smilowitz, J. T., Tassone, F., & Giulivi, C. (2016). Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding. Frontiers in neuroscience, 10159. https://doi.org/10.3389/fnins.2016.00159
Napoli, Eleonora, et al. "Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding." Frontiers in neuroscience vol. 10 (2016): 159. doi: https://doi.org/10.3389/fnins.2016.00159
Napoli E, Ross-Inta C, Song G, Wong S, Hagerman R, Gane LW, Smilowitz JT, Tassone F, Giulivi C. Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding. Front Neurosci. 2016 Apr 19;10:159. doi: 10.3389/fnins.2016.00159. eCollection 2016. PMID: 27147951; PMCID: PMC4835505.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 614 entries